Press release

Adents Introduces DispaX, a New Mobile Application to Manage Serialized Products in the Supply Chain

Adents DispaX allows all supply chain stakeholders to verify, decommission, and aggregate serialized products.

Leading serialization and track & trace solutions provider Adents has introduced a new mobile application developed for pharmaceutical warehouses, wholesalers, distributors and dispensers (such as pharmacies and hospitals) for improved traceability throughout the supply chain.

Adents DispaX is a secure, user-friendly and multi-taskable solution allowing for identification of serial numbers at various stages of the supply chain by a series of users, complying with local regulations in a number of geographies around the world. Integrated into the Adents Prodigi application marketplace, DispaX provides the serialization software for handheld scanners and mobile devices, including smartphones. The application enables users to query by lot, delivery number, serial number and levels up and down the hierarchy tree as the industry continues its steady march toward comprehensive aggregation.

A number of valuable features are available to DispaX users, including the ability to see all details of an item, navigate up and down parent-child aggregation relationships, manage the products picking and view shipment history. Since the mobile application is a natural extension of Prodigi, all users actions are logged in the audit trail.

The convenient, intuitive solution offers three ways to search data: scanning a label, entering a serial or delivery number, or entering a lot number.

“Adents DispaX is designed to assist supply chain stakeholders in decommissioning, recommissioning, aggregating, disaggregating and verifying serial numbers in a user-friendly fashion,” said Christophe Devins, founder & CEO of Adents. “The innovative solution enriches the catalog of Adents Prodigi applications, our Level 4-5 platform proudly co-developed with Microsoft.”

Silvain Vernet


COVID-19: Adents' Business Continuity plan
The COVID-19 coronavirus epidemic has already affected thousands of people around the world and we expect the French government to announce stricter containment measures soon. Since Adents employees are mainly based in France and the United States, we take the health and economic risks linked to this epidemic very seriously.
Laboratoires Théa addresses European FMD and South Korea market regulation requirements with Adents Cloud serialization solution
Leading Ophtalmic Pharmaceuticals Company chose Adents Prodigi to connect with approximately 15 supply chain partners to stay compliant with current and future regulations.
Pharmascience Chooses Software from Adents to Ensure European FMD and US DSCSA Serialization Compliance Regulations
Pharmascience,the 4th largest manufacturer of over-the-counter and generic drugs in Canada, has chosen to partner with Adents, a leading provider of versatile and easily deployable serialization and track-and-trace software solutions, to assure compliance with the European Falsified Medicines Directive as well as the U.S. DSCSA serialization regulation.